Loading...
XNASBIMI
Market cap104kUSD
Dec 20, Last price  
0.01USD
1D
-11.76%
1Q
-62.50%
IPO
-99.98%
Name

Bimi International Medical Inc

Chart & Performance

D1W1MN
XNAS:BIMI chart
P/E
—
P/S
0.01
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
79.89%
Rev. gr., 5y
6.82%
Revenues
12m
-56.31%
0005,269,01310,336,44915,834,94420,323,99725,372,20614,929,4309,269,0165,674,9339,980,9176,714,8696,041,2618,508,1736,542,232157,97812,844,90227,079,79511,830,379
Net income
-22m
L-38.07%
-292,076-344,357-399,259790,9612,068,7063,652,8104,775,8794,302,7642,046,46088,034-180,165-617,291-969,442-1,817,579-1,569,817-16,786,509-3,895,324-3,786,035-34,921,745-21,628,406
CFO
-10m
L+703.87%
-190,470-363,546-176,677-1,255,750776,595-12,5122,929,8983,359,9982,488,5734,559,248892,708-995,080-2,473,729159,832-908,229-343,970-2,064,792-3,517,733-1,275,725-10,255,206

Profile

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.
URL
https://usbimi.com/
IPO date
Oct 04, 2010
Employees
296
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
11,830
-56.31%
27,080
110.82%
Cost of revenue
21,783
35,187
Unusual Expense (Income)
NOPBT
(9,953)
(8,107)
NOPBT Margin
Operating Taxes
6
19
Tax Rate
NOPAT
(9,959)
(8,126)
Net income
(21,628)
-38.07%
(34,922)
822.38%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,000
3,818
BB yield
-152.55%
-1,396.04%
Debt
Debt current
2,566
8,334
Long-term debt
5,997
9,816
Deferred revenue
Other long-term liabilities
2,245
Net debt
4,426
19,292
Cash flow
Cash from operating activities
(10,255)
(1,276)
CAPEX
(815)
Cash from investing activities
(537)
(697)
Cash from financing activities
8,434
6,141
FCF
(3,634)
(20,361)
Balance
Cash
2,337
4,798
Long term investments
1,800
(5,940)
Excess cash
3,545
Stockholders' equity
(66,682)
(43,884)
Invested Capital
79,528
67,591
ROIC
ROCE
EV
Common stock shares outstanding
2,665
11
Price
1.23
-95.18%
25.50
-69.46%
Market cap
3,278
1,098.42%
273
-98.47%
EV
8,873
19,709
EBITDA
(9,729)
(7,863)
EV/EBITDA
Interest
3,431
351
Interest/NOPBT